3Catalano L,Selleri C,Califano C,et al.Prolonged response to cyclosporin-A in hypoplastic refractory anemia and correlation with in vitro studies.Haematolojica,2000,85:133～138.
4Raza A,Lisak L,Billmeier J,et al,Arsenic Trioxide with/without Thalidomid in patients with myelodysplastic syndromes(MDS)produces hemotologic improvement.Blood,2004,104:2616.
7List AF,Brasfield F,Heaton R,et al.Stimulation of hematopoiesis by amifostine in patients with myelodysplastic syndrome.Blood,1997,3364～3369.
8Candoni A,Raza A,Silvestri F,et al.Response rate and survival after thalidomide-based therapy in 248 patients with myelodysplastic syndromes Ann hematol,2005,Jul;84(7)479 ～481.
9Raza A,Meyer P,Dutt D,et al.Thalidomide produces transfusion independeuce in long-standing refractory anemias of patients with myelodysplastic syudromes.Blood,2001,98:958～965.
10List A,Kurtin S,Roe DJ,et al.Efficacy of lenalidomide in myelodyplastic syndromes N Engl J Med,2005,Feb10;352(6):549～557.
二级参考文献42
1Stetler - Stevenson M, Arthur DC, Jabbour N, et al. Blood, 2001,98: 979
